These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11239257)

  • 41. [What is the most relevant definition of orthostatic hypotension: systolic blood pressure drop, diastolic blood pressure drop, or both?].
    Duron E; Lenoir H; Pequignot R; Lefèvre M; Rigaud AS; Hanon O
    Arch Mal Coeur Vaiss; 2007 Aug; 100(8):689-94. PubMed ID: 17928778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diagnostic and therapeutic procedures by doctors for patients in a hypertensive crisis. An inquiry in 56 internal medicine clinics].
    Wenzel UO; Stahl RA; Grieshaber M; Schwietzer G
    Dtsch Med Wochenschr; 1998 Apr; 123(15):443-7. PubMed ID: 9581158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil.
    Wacker JR; Wagner BK; Briese V; Schauf B; Heilmann L; Bartz C; Hopp H
    Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):160-5. PubMed ID: 16253414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension.
    Mallion JM; Dutrey-Dupagne C; Vaur L; Genes N; Renault M; Elkik F; Baguet P; Boutelant S
    J Hypertens; 1996 Jan; 14(1):137-44. PubMed ID: 12013487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood pressure control in patients with hypertension: a community-based study.
    Wang L; Wei T
    Clin Exp Hypertens; 2006 Jan; 28(1):41-6. PubMed ID: 16443563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eprosartan mesylate effectively reduces systolic and diastolic blood pressure in a Canadian primary care setting.
    Conter HS; McKay DW; Reiz RJ
    Can J Cardiol; 2004 Oct; 20 Suppl C():6C-10C. PubMed ID: 16807617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intubating conditions and hemodynamic effects of etomidate for rapid sequence intubation in the emergency department: an observational cohort study.
    Zed PJ; Abu-Laban RB; Harrison DW
    Acad Emerg Med; 2006 Apr; 13(4):378-83. PubMed ID: 16531603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Use of injectable urapidil in pregnancy-induced hypertension and preeclampsia].
    Carles G; Helou J; Dallah F; Ibrahim N; Alassas N; Youssef M
    J Gynecol Obstet Biol Reprod (Paris); 2012 Nov; 41(7):645-9. PubMed ID: 22726863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Value of propranolol-induced heart rate and blood pressure changes in predicting results of tilt testing.
    Gielerak G; Kozłowski D; Dłuzniewska E; Roszczyk A; Cholewa M
    Kardiol Pol; 2003 Feb; 58(2):98-108. PubMed ID: 14504635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and Safety of Intravenous Urapidil for Older Hypertensive Patients with Acute Heart Failure: A Multicenter Randomized Controlled Trial.
    Yang W; Zhou YJ; Fu Y; Qin J; Qin S; Chen XM; Guo JC; Wang Z; Zhan H; Li J; He JY; Hua Q
    Yonsei Med J; 2017 Jan; 58(1):105-113. PubMed ID: 27873502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Urapidil effects on oxidative stress in hypertensive crises].
    Golikov PP; Davydov BV; Marchenko VV; Nikolaeva NIu; Golikov AP; Riabinin VA; Semenova EV; Polumiskov VIu
    Klin Med (Mosk); 2000; 78(7):42-5. PubMed ID: 10979642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Control of hypertension during cardiopulmonary bypass with urapidil and phentolamine.
    Göb E; Barankay A; Richter JA
    Arzneimittelforschung; 1981; 31(9):1479-81. PubMed ID: 7197959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravenous urapidil versus sublingual nifedipine in the treatment of hypertensive urgencies.
    Hirschl MM; Seidler D; Zeiner A; Wagner A; Heinz G; Sterz F; Laggner AN
    Am J Emerg Med; 1993 Nov; 11(6):653-6. PubMed ID: 8240575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative hemodynamic effects of urapidil and labetalol after electroconvulsive therapy.
    Blanch J; Martínez-Pallí G; Navinés R; Arcega JM; Imaz ML; Santos P; Faulí A; Bernardo M; Gomar C
    J ECT; 2001 Dec; 17(4):275-9. PubMed ID: 11731729
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Metabolically neutral therapy of hypertension. An open, multicenter, prospective long-term study of the tolerance, safety and effectiveness of urapidil].
    Liebau H; Wurst W; Harder I; Solleder P
    Fortschr Med; 1988 Nov; 106(32):651-4. PubMed ID: 3148534
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hypertensive crisis in cardiology: place of urapidil].
    Kobalava ZhD; Kotovskaia IuV; Bagmanova NKh; Artiukhov OP; Darmaeva IP
    Kardiologiia; 2012; 52(1):86-90. PubMed ID: 22304359
    [No Abstract]   [Full Text] [Related]  

  • 59. Urapidil-induced hemodynamic changes in humans.
    Bielen E; Fagard R; Staessen J; Lijnen P; Van Hoof R; Amery A
    Am J Cardiol; 1989 Aug; 64(7):16D-21D. PubMed ID: 2667309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urapidil permeates the intact blood-brain barrier.
    Castor G; Schmidt U
    Intensive Care Med; 1994; 20(4):278-81. PubMed ID: 7519201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.